Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Daito Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is June - May.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 15, 2025	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020
Market Capitalization	29,836	34,043	33,086	37,154	44,980	56,950
Market Cap Growth	-5.18%	2.89%	-10.95%	-17.40%	-21.02%	35.25%
Enterprise Value	38,036	37,799	34,956	37,065	46,116	58,118
Last Close Price	1990.00	2188.83	1999.65	2218.60	2718.74	3565.94
PE Ratio	14.03	10.33	9.19	7.96	10.59	14.44
Forward PE	15.31	8.98	9.39	8.00	10.05	17.46
PS Ratio	0.61	0.73	0.73	0.86	0.92	1.27
PB Ratio	0.58	0.65	0.65	0.78	1.07	1.55
P/TBV Ratio	0.58	0.66	0.66	0.79	1.09	1.57
P/FCF Ratio	-	-	-	-	-	36.16
P/OCF Ratio	-	6.57	7.96	8.50	8.68	13.23
EV/Sales Ratio	0.78	0.81	0.78	0.85	0.95	1.29
EV/EBITDA Ratio	6.10	5.00	3.85	3.75	5.08	6.99
EV/EBIT Ratio	13.93	9.71	6.71	5.64	7.80	10.84
EV/FCF Ratio	-	-	-	-	-	36.90
Debt / Equity Ratio	0.20	0.17	0.10	0.07	0.08	0.09
Debt / EBITDA Ratio	-	1.15	0.55	0.35	0.37	0.38
Debt / FCF Ratio	-	-	-	-	-	2.01
Asset Turnover	0.63	0.63	0.67	0.71	0.87	0.89
Inventory Turnover	1.90	1.89	1.98	1.97	2.72	3.20
Quick Ratio	1.24	1.05	1.38	1.46	1.26	1.24
Current Ratio	2.66	2.24	2.64	2.70	2.52	2.05
Return on Equity (ROE)	3.85%	6.16%	7.15%	10.33%	10.55%	11.51%
Return on Assets (ROA)	2.16%	3.28%	4.81%	6.69%	6.60%	6.64%
Return on Capital (ROIC)	2.74%	4.16%	6.09%	8.51%	8.67%	8.77%
Return on Capital Employed (ROCE)	4.30%	6.60%	9.50%	12.90%	13.20%	13.70%
Earnings Yield	7.28%	9.68%	10.88%	12.56%	9.44%	6.93%
FCF Yield	-	-3.05%	-4.08%	-0.69%	-2.53%	2.77%
Dividend Yield	3.52%	2.74%	2.73%	2.05%	1.54%	1.02%
Payout Ratio	-	27.53%	25.86%	14.14%	15.50%	12.73%
Buyback Yield / Dilution	4.00%	0.86%	-3.38%	-1.94%	-6.42%	-2.53%
Total Shareholder Return	7.52%	3.61%	-0.66%	0.11%	-4.88%	-1.51%

Updated Jan 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.